SCHEDULE: Pzena Investment Management Boosts USANA Stake to 6.6%

Pzena Investment Management, LLC has reported a 6.6% beneficial ownership stake in USANA Health Sciences Inc. common stock.

Summary

• Pzena Investment Management, LLC reported beneficial ownership of 1,212,588 shares of USANA Health Sciences Inc. common stock.
• This represents 6.6% of the total class of securities.
• The event requiring this filing occurred on September 30, 2025.
• Pzena Investment Management, LLC holds sole voting power over 903,278 shares and sole dispositive power over 1,212,588 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investment, which can be viewed positively as a vote of confidence, but it is a passive ownership disclosure without performance metrics or strategic updates.

Positives

• Increased institutional ownership by Pzena Investment Management, LLC, holding 6.6% of USANA Health Sciences Inc. common stock.
• The investment is stated to be in the ordinary course of business, indicating a passive, long-term interest rather than an activist stance.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

The filing reflects continued institutional interest in the health sciences sector, with Pzena Investment Management, a value-oriented investment firm, taking a significant passive stake in USANA Health Sciences Inc.

Stakeholder Impact

• Shareholders: Increased institutional ownership may signal confidence and potentially stabilize the stock.

Key Dates

Recommendation

The filing indicates a significant institutional stake by Pzena Investment Management, LLC, which can be a positive signal for market confidence. However, as a Schedule 13G, it does not provide financial performance data or strategic updates to warrant a stronger recommendation. It primarily reflects a passive investment position.

Keywords

USANA Health Sciences, Pzena Investment Management, institutional ownership, common stock, Schedule 13G, investment adviser, beneficial ownership